Myopic Traction Maculopathy: A New Perspective on Classification and Management

Area of Science:

• Ophthalmology
• Retinal Diseases
• Surgical Innovation

Background:

• Myopic traction maculopathy (MTM) affects up to 30% of eyes with pathologic myopia.
• Understanding MTM's pathogenesis, definition, and natural evolution is crucial for effective management.
• Recent studies have clarified MTM, leading to the development of the MTM Staging System (MSS).

Purpose of the Study:

• To review the historical treatment of MTM, detailing success rates and limitations of various surgical techniques.
• To propose stage-specific management guidelines for MTM based on the MSS.
• To provide insights into the pathogenesis and natural evolution of MTM through the MSS.

Main Methods:

• Review of historical surgical techniques for MTM.
• Analysis of success rates and limitations of different treatment modalities.
• Application of the MTM Staging System (MSS) to categorize MTM severity and guide treatment decisions.

Main Results:

• Early MTM stages (1a, 2a) characterized by maculoschisis require observation.
• Macular detachment stages (3a, 4a) are treated with a macular buckle (MB).
• Lamellar (1b) and full-thickness macular holes (1c) are managed with pars plana vitrectomy (PPV), with MB added for advanced stages (2b-4c) or combined with PPV.

Conclusions:

• Treatment for MTM should be tailored to the specific stage defined by the MSS.
• Macular buckle (MB) and pars plana vitrectomy (PPV) are key surgical interventions, with combinations indicated for advanced disease.
• The proposed guidelines offer a structured approach to managing MTM, aiming to improve visual outcomes.